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with a male: female sex ratio of 2.5: 1. Fungal culture 
was positive in 85.71% whereas AEC was increased 
in 42.86% cases. Microscopic evidence and antibody 
response was detectable in only 2 cases each (28.57%). 
None of the cases showed a positive skin response. 
Conclusions: It is emphasized that in the light of a strong 
clinical suspicion, a rigorous laboratory work up in the 
form of microscopy, culture and immunological studies 
is warranted for an early diagnosis and management of 
IA in order to avoid serious and fatal complications. 
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Background: Paecilomyces lilacinus is a rare oppor- 
tunistic pathogen in man and due to in vitro resistance 
to amphotericin B treatment is extremely difficult. 
Successful therapy with ketoconazole, itraconazole, 
and terbinafine has been sporadically reported although 
optimal treatment for serious infections due to I? lilacinus 
remains uncertain. 
Results: A cluster of red nodules developed in a 64-year- 
old diabetic woman with metastatic adenocarcinoma of 
the pancreas. In the following two weeks, an extensive 
area involving the right lower leg and isolated cluster of 
lesion in the medial mid-thigh were noticed. Six months 
earlier, she had received weekly gemcitabine (1000 
mg/m”). She also underwent multiple hospitalizations 
for severe asthma exacerbation requiring high-dose 
corticosteroides in the preceding three months. Extensive, 
excoriated nodules and pustules overlying erythematous 
and indurated base were present on examination of the 
right lower extremity. WBC 10.8 x lO?uL, creatinine 3.3 
mg/ml, LDH 389 U/L, AST 46 U/L, and ESR 16 mm/h. 
Blood cultures were sterile. No acute pulmonary process 
was seen on chest computed tomography scan. Within 
three days, prominent growth (5 to 10 colonies) of 
Paecilomyces lilacinus was isolated from several skin 
lesions. The in vitro antifungal susceptibility was deter- 
mined at two intervals (MIC (g/ml; 48 h and 72 h) 
and are as follows: amphotericin B 16.0 and 16.0, 
ketoconazole 1.0 and 1.0, itraconazole 1.0 and 4.0, 
voriconazole 0.25 and 0.25, posaconazole 0.125 and 
0.125, ravuconazole 0.5 and 1.0, and caspofungin 1.0 and 
4.0. Treatment with oral itraconazole 600 mg daily (for 
3 days) than 400 mg daily was initiated. Seven days later, 
caspofungin 70 mg, than 50 mg daily was added due to 
lack of clinical response. In the following week, 
excoriated nodules involving the mid-thigh, and lower 
leg resolved. No new pustules were noticed. Treatment 
was continued for four weeks, with complete resolution 
of the P lilacinus infection, and there were no significant 
side effects of the therapy. 
Conclusions: Since 1977, less than 25 cases of cutaneous 
Paecilomyces infection have been reported. Suscepti- 
bility to amphotericin B, flucytosine, triazole-based 
agents is variable and P lilacinus frequently shows in 
vitro resistance to the currently available agents. The in 
vitro susceptibility profiles of the newer, broad-spectrum 
triazoles appears to be promising, and treatment with 
combination antifungals in my patient lead to rapid 
clearing of infection. 
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Background: Most invasive Candida infection arises 
from hosts’ endogenous flora, and critically ill patients 
with prominent Candida colonization are considered at 
risk for near-future systemic invasion. This association in 
non-critically ill adults with cancer is unclear. 
Methods: During July 11998 to April 14 1999,193 patients 
with prominent colonization (~50 Candida colonies 
from nonsterile source) were evaluated prospectively, 
and followed for 14 weeks after the initial cultures. 
Results: Solid-organ cancer was most common (129) 
Cancer, 43 had hematological malignancies, and 17 
underwent allogeneic marrow graft transplantation. Six 
had AIDS, and 13 with benign conditions. Fifty-three 
(27.5%) patients expired, of these 25 (19.4%) had solid- 
organ cancer, 60.5% with hematological malignancy. 
Eleven (65%) marrow transplantation recipients died. 
No deaths were observed in patients with AIDS, and one 
in those with benign diseases. Among 53 that died, 26 
(49%) had respiratory tract colonization, 13 (24.5%) GI 
tract and 3 (5.7%) GU tract. Fifty percent with 22 body 
site colonization expired and all 4 patients (100%) with 
two respiratory tract sites died. Twenty-one percent died 
with a single site C. albicans colonization, and 53.8% 
with ~2 sites involved, similarly for C. glabrata 46.7% 
with single site, and 100% with multiple sites. Single site 
colonization and mortality was highest for C. krusei 
(75%), while in case of C. tropicalis (30%) and C. 
parapsilosis (25%) it was substantially lower. Four 
patients (18.2%) among those with r2 Candida species 
colonization expired, 100% mortality in patients with C. 
albicans+ C, krusei dual species colonization, while 20% 
in 10 patients with C. albicans+C. glabrata. NO short- 
term mortality was seen in patients with C. albicans + C. 
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tropicalis; C. glabrata + C. kefyr and those with 3 Candida 
species colonization. 
Conclusions: This casual relationship between prominent 
Candida colonization and adverse impact on short-term 
mortality especially, in patients with hematological cancer 
and BMT recipients was not surprising. High mortality in 
patients with C. glabrata and C. krusei multiple sites 
and/or multiple species colonization was documented. 
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Invasive aspergillosis (IA) is a common fungal infection 
in immunocompromised patients with a high mortality 
rate. We report the case of a 49-year old man with history 
of fever and chills 4 months after kidney transplantation. 
Physical examination and chest radiography were 
normal. Laboratory tests showed CRP elevation (78 
mg/l). Blood cultures and urine bacteriology were sterile. 
Cytomegalovirus-antigenemia negative. Computed 
tomography (CT) of the chest discluded a small nodular 
lesion (1,2 cm) in the left lower lobe. No pathogenic 
organism was identified by bronchoalveolar lavage. 
Serology for toxoplasmosis and cryptococcal antigen 
were negative. Control CT of the chest 2 weeks later 
revealed minimal progression of the pulmonary lesion 
and an in-homogenous enlargement of the thyroid 
gland. Fine needle aspiration of the thyroid revealed 
growth of Aspergillus jumigatus. Inspite of anti-fungal 
therapy with liposomal Amphotericin B the patient 
remained febrile. Echocardiography and MRI of the 
heart showed fibrotic pericarditis and several myocardial 
abscesses, suggesting disseminated IA. Caspofungin and 
flucytosine was added to amphotericin B. Flucytosine 
was stopped after 2 weeks because of leukopenia. 
Three months after the therapy of amphotericin B and 
caspofungin, we observed favourable clinical course, 
regression of the pulmonary lesions and vanishing of the 
myocardial abscesses. The patient was discharged on oral 
itraconazole. In conclusion, we report an unusual clinical 
presentation of invasive aspergillosis with multiple myo- 
cardial abscesses in an immunocompromised patient 
with favourable outcome under experimental antifungal 
combination therapy. 
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malignaucies (HM) 
N. S. Bagirova and N. I/: Dmitrieva 
N. N. Blokhin Cancer Research Centre of Russia, 
Moscow, Russia 
Objectives: To receive a database, which is a basis for 
realization of effective preventive and empiric therapy 
of severe fungal infections in PTS with HM. 
Methods: The monitoring for selection of yeasts from 
different samples (urine, throat, blood, stool and others) 
during 2000-01 was performed. The standard techniques 
of microbiological research were used. The strains were 
identified by the selective medium (CROMagar, Becton 
Dickinson), “Auxacolor” (BIO-RAD) too. Susceptibility 
tests to antifungal drugs (6 agents) were performed with 
“Fungitest” (BIO-RAD). In our study BACTEC 9050 
blood culture system (Becton Dickinson Diagnostic 
instrument Systems) was used (Blood specimens were 
inoculated into BACTEC Mycosis-I(X). 
Results: A total of 590 strains from 294 PTS with HM 
between 2000 and 2001 were obtained. From 316 samples 
fungi were isolated in 8.9 % of cases in association (more 
than one strain from the same sample). 21 positive blood 
cultures from 14 PTS were obtained (only Candida spp., 
64% of them were non-albicans Candida species). There 
were 3 genera of yeasts in our hospital. Among them 
Candida spp, Geotrichum spp., Saccharomyces spp.. 
Candida spp represented 93.7% of all yeast isolates 
(C. albicans - 67.3%, C. glabrata - 8.2%, C. inconspicua 
- 7.0%, C. kefur - 3.1%, C. tropicalis - 2.9%, C. 
parapsilosis - 2.7%) C. krusei - 0.9%, C. lusitaniae - 
0.7%, C. rugosa - 0.4%, C. lipolytica - 0.2%). Non- 
albicans Candida species represented 28.2% of all 
Candida spp. We performed susceptibility tests of yeasts. 
No strain of yeasts was resistant to amphotericin B. 
Susceptibility testing of fungi revealed that the majority 
of the strains were sensitive to fluconazole, itraconazole, 
ketoconazole, miconazole, 5-fluorocytosine. 
Conclusion: The results of this study demonstrate that 
the predominant pathogens were Candida spp.. All 
strains of yeasts were susceptible to amphotericin B. 
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We investigated the in vitro susceptibility of Aspergillus 
fumigatus to 2-d rug combination of amphotericin B lipid 
complex (ABLC) and liposomal amphotericin B (L- 
AMB) with caspofungin (CFG) and micafungin (MFG), 
and the results were compared with those obtained for 
pair-wise combination of conventional amphotericin B 
(C-AMB) with CFG and MFG. Conidial suspensions 
were prepared from 20 clinical isolates of A. fumigatus 
(Microbiology Laboratory, Detroit Medical Center, 
Detroit,Michigan) susceptible to ABLC (MIC 1.26k1.14 
kg/mL), L-AMB (MIC 1.950.87 kg/mL) C-AMB (MIC 
l(O.0 kg/mL), and CFG (MIC 64kO.O kg/mL) and MFG 
(MIC 217.6261.82 kg/mL).The in vitro susceptibility of 
